Stark choices
Exploring health sector costs of policy responses to Covid-19 in low-income and middle-income countries
Bibliographic Data
OBJECTIVES: COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under different epidemiological scenarios. METHODS: We used country-specific epidemiological projections from a dynamic transmission model to determine number of cases, hospitalisations and deaths over 1 year under four mitigation scenarios. We defined the health sector response for three base LMICs through guidelines and expert opinion. We calculated costs through local resource use and price data and extrapolated costs across 79 LMICs. Lastly, we compared cost estimates against gross domestic product (GDP) and total annual health expenditure in 76 LMICs. RESULTS: COVID-19 clinical management costs vary greatly by country, ranging between <0.1%-12% of GDP and 0.4%-223% of total annual health expenditure (excluding out-of-pocket payments). Without mitigation policies, COVID-19 clinical management costs per capita range from US$43.39 to US$75.57; in 22 of 76 LMICs, these costs would surpass total annual health expenditure. In a scenario of stringent social distancing, costs per capita fall to US$1.10-US$1.32. CONCLUSIONS: We present the first dataset of COVID-19 clinical management costs across LMICs. These costs can be used to inform decision-making on priority setting. Our results show that COVID-19 clinical management costs in LMICs are substantial, even in scenarios of moderate social distancing. Low-income countries are particularly vulnerable and some will struggle to cope with almost any epidemiological scenario. The choices facing LMICs are likely to remain stark and emergency financial support will be needed
Business · Economic cost · Economic growth · Economics · Environmental health · Gross domestic product · Health care · Health economics · Per capita · Population · Public economics · Social distance · COVID-19 epidemiological studies · Global Maternal and Child Health · Healthcare Systems and Reforms · Medicine
Exploring equity in health and poverty impacts of control measures for Sars-CoV-2 in six countries
High-cost users still came to hospitals during the Covid-19 pandemic during first wave data in Thailand
Covid-19 Vaccine Acceptance and Its Determinants among Myanmar Migrant Workers in Southern Thailand
Out-of-pocket expenditure and catastrophic costs due to Covid-19 in Indonesia
Health impact and cost-effectiveness of Covid-19 booster vaccination strategies in the early post-Omicron era
Stewarding Covid-19 health systems response in Pakistan
Is there a role for RDTs as we live with Covid-19? An assessment of different strategies
What, how and who
Cost analysis of Covid-19 treatment and its cost drivers
Do private health providers help achieve Universal Health Coverage? A scoping review of the evidence from low-income countries
Effects of non-pharmaceutical interventions on Covid-19 cases, deaths, and demand for hospital services in the UK
An interactive web-based dashboard to track Covid-19 in real time
Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the Covid-19 pandemic
| Unique citing works | 10 |
|---|---|
| Citations per year | 2 |
| Citation span | 2021 - 2026 (6) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 9 |